• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.

作者信息

Dallas Jennifer L, Jantz Michael A, Lightsey Judith L, Sonntag Christopher, Kaye Frederic J

机构信息

Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida 32610, USA.

出版信息

J Thorac Oncol. 2011 Jun;6(6):1142-3. doi: 10.1097/JTO.0b013e318217b684.

DOI:10.1097/JTO.0b013e318217b684
PMID:21623280
Abstract
摘要

相似文献

1
Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.厄洛替尼诱发间质性肺病后再次成功使用厄洛替尼治疗。
J Thorac Oncol. 2011 Jun;6(6):1142-3. doi: 10.1097/JTO.0b013e318217b684.
2
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: a case report and review of the literature.厄洛替尼诱导的间质性肺病后肺腺癌脑膜转移再次成功厄洛替尼治疗：病例报告及文献复习。
Lung Cancer. 2012 Aug;77(2):464-8. doi: 10.1016/j.lungcan.2012.04.013. Epub 2012 May 12.
3
Both gefitinib and erlotinib induced drug-related interstitial lung disease in a patient with pulmonary adenocarcinoma.吉非替尼和厄洛替尼均导致肺腺癌患者发生药物相关性间质性肺病。
J Chin Med Assoc. 2013 Mar;76(3):173-5. doi: 10.1016/j.jcma.2013.01.012. Epub 2013 Feb 27.
4
Successful erlotinib rechallenge after gefitinib-induced acute interstitial pneumonia.吉非替尼诱发急性间质性肺炎后厄洛替尼再次治疗成功。
J Thorac Oncol. 2010 Jul;5(7):1105-6. doi: 10.1097/JTO.0b013e3181dc39cd.
5
Successful treatment with erlotinib after gefitinib-induced interstitial lung disease: a case report and literature review.吉非替尼诱发间质性肺病后使用厄洛替尼成功治疗：一例报告及文献综述
Int J Clin Pharmacol Ther. 2012 Oct;50(10):760-4. doi: 10.5414/CP201759.
6
High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer.非小细胞肺癌患者中厄洛替尼高暴露与严重药物性间质性肺病
Lung Cancer. 2014 Oct;86(1):113-4. doi: 10.1016/j.lungcan.2014.07.021. Epub 2014 Aug 2.
7
Fatal interstitial lung disease after erlotinib for non-small cell lung cancer.厄洛替尼治疗非小细胞肺癌后发生的致命性间质性肺病。
J Thorac Oncol. 2008 Sep;3(9):1050-3. doi: 10.1097/JTO.0b013e318183a9f5.
8
Fatal asymmetric interstitial lung disease after erlotinib for lung cancer.厄洛替尼治疗肺癌后致死性非对称间质性肺病。
Respiration. 2012;84(5):431-5. doi: 10.1159/000339508. Epub 2012 Aug 9.
9
Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).一名先前耐受吉非替尼（易瑞沙）的患者在使用厄洛替尼（特罗凯）后出现间质性肺病。
J Oncol Pharm Pract. 2005 Sep;11(3):127-30. doi: 10.1191/1078155205jp158cr.
10
Pulmonary toxicity associated with erlotinib.与厄洛替尼相关的肺部毒性。
Chest. 2007 Sep;132(3):1042-4. doi: 10.1378/chest.07-0050.

引用本文的文献

1
Re-administration of Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Who Recovered from Chemotherapy-induced Interstitial Lung Disease.化疗诱导的间质性肺疾病康复后的晚期非小细胞肺癌患者再次化疗
In Vivo. 2018 Jul-Aug;32(4):851-857. doi: 10.21873/invivo.11319.
2
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma.一名肺腺癌患者在奥希替尼诱发肺炎后成功再次使用奥希替尼治疗。
Respir Med Case Rep. 2017 Dec 11;23:68-70. doi: 10.1016/j.rmcr.2017.12.005. eCollection 2018.
3
Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease.
奥希替尼诱导的间质性肺疾病后采用类固醇治疗成功再次使用奥希替尼
Intern Med. 2018 Jan 1;57(1):91-95. doi: 10.2169/internalmedicine.8947-17. Epub 2017 Oct 16.
4
Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.表皮生长因子受体突变型肺癌患者在厄洛替尼诱发肺炎后成功使用阿法替尼
Clin Lung Cancer. 2017 Jan;18(1):e81-e83. doi: 10.1016/j.cllc.2016.10.001. Epub 2016 Oct 26.